Education/CredentialsFellowship : University of Cincinnati (Infectious Diseases )Residency : University of Cincinnati (Internal Medicine )Medical Degree: University of OklahomaBachelor's Degree: University of Oklahoma (Microbiology) Board Certifications & LicensesAmerican Board of Internal Medicine (Infectious Disease) (Certification Date: 2006-10-24) - (Recertification Date: 2016-11-07)American Board of Internal Medicine (Certification Date: 2004-08-24) - (Recertification Date: 2015-02-03) SpecialtiesInfectious DiseasesInternal Medicine Contact Information Office 513-584-5827 Email roberj5@ucmail.uc.edu Research InterestsHIV / AIDS And HPV-Associated Anal Dysplasia Clinical Interests Infectious DiseaseHepatitis C Virus (HCV)HIV/AIDS (Human immunodeficiency virus) Peer Reviewed Publications Robertson, Jaime; Feinberg, Judith 2012. Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection. Expert opinion on pharmacotherapy, 13 9, 1363-75Robertson, Jaime; Meier, Matthew; Wall, Jennifer; Ying, Jun; Fichtenbaum, Carl J 2006. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 11, 1639-46Smulian, A George; Moore, Diana M; Robertson, Jaime C; Kralovic, Stephen M . Phase I study demonstrates safety and tolerability of radiofrequency ablation (RFA) of the anal mucosa. HIV clinical trials, 15 1, 36-44
Peer Reviewed Publications Robertson, Jaime; Feinberg, Judith 2012. Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection. Expert opinion on pharmacotherapy, 13 9, 1363-75Robertson, Jaime; Meier, Matthew; Wall, Jennifer; Ying, Jun; Fichtenbaum, Carl J 2006. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 11, 1639-46Smulian, A George; Moore, Diana M; Robertson, Jaime C; Kralovic, Stephen M . Phase I study demonstrates safety and tolerability of radiofrequency ablation (RFA) of the anal mucosa. HIV clinical trials, 15 1, 36-44
Robertson, Jaime; Feinberg, Judith 2012. Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection. Expert opinion on pharmacotherapy, 13 9, 1363-75Robertson, Jaime; Meier, Matthew; Wall, Jennifer; Ying, Jun; Fichtenbaum, Carl J 2006. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 11, 1639-46Smulian, A George; Moore, Diana M; Robertson, Jaime C; Kralovic, Stephen M . Phase I study demonstrates safety and tolerability of radiofrequency ablation (RFA) of the anal mucosa. HIV clinical trials, 15 1, 36-44